Inflammation Injury and Selected Disease Processes Causing Aortic Root and Aortic Valvular Inflammation Flashcards

1
Q

What is Marfan syndrome (MFS)?

A

An autosomal dominant disease characterized by cardiovascular, ocular, and skeletal problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the estimated prevalence of Marfan syndrome?

A

1 in 3000–5000 individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In what percentage of Marfan syndrome cases do affected individuals have unaffected parents?

A

Approximately one-third.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common cardiovascular complication in patients with Marfan syndrome?

A

Progressive aortic root enlargement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are potential outcomes of ascending aortic aneurysms in Marfan syndrome?

A

Acute type A aortic dissection, aortic rupture, or aortic regurgitation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the management approach for aortic disease in Marfan syndrome patients?

A

Regular imaging, β-adrenergic receptor antagonist therapy, and prophylactic aortic repair when dilation is ≥5.0 cm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What was the average life expectancy of patients with Marfan syndrome before surgical repair options became available?

A

45 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What has improved the average life expectancy of patients with Marfan syndrome to 70 years?

A

Improvements in medical and surgical management of aortic disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does aortic root dilatation typically begin in Marfan syndrome?

A

At the sinuses of Valsalva.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should be evaluated annually in patients with Marfan syndrome?

A

The proximal aorta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What imaging techniques are useful for assessing aortic root size?

A

Transthoracic echocardiography, magnetic resonance imaging, and transesophageal echocardiography.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When is prophylactic aortic root replacement recommended?

A

When the diameter reaches 5.0 cm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the cumulative risk increase of aortic rupture or dissection when an aneurysm exceeds 6 cm?

A

A fourfold increase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a composite valve graft replacement?

A

A surgical procedure involving mobilizing buttons of aortic tissue around coronary arteries for anastomosis to an aortic graft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the most common causes of late death after composite valve graft repair?

A

Dental work, invasive procedures, dissection or rupture of the residual distal aorta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are ‘valve-sparing’ aortic root replacement procedures?

A

Surgical procedures that preserve the patient’s native aortic valve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the Yacoub procedure known as?

A

The ‘remodeling’ technique.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the David procedure considered?

A

The ‘reimplantation’ technique.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are some skeletal manifestations of Marfan syndrome?

A

Tall stature, long fingers and toes, joint laxity, pectus carinatum, and scoliosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What ocular manifestation is common in Marfan syndrome?

A

Ectopia lentis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What percentage of patients with Marfan syndrome have mitral valve prolapse?

A

70–90%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the primary method for diagnosing Marfan syndrome?

A

The Ghent criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the two cardinal features of Marfan syndrome according to the revised Ghent criteria?

A

Aortic root aneurysm/dissection and ectopia lentis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What gene is primarily associated with Marfan syndrome?

A

Fibrillin gene (FBN1) on chromosome 15.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What type of mutations are most commonly found in FBN1 related to Marfan syndrome?

A

Missense mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is relapsing polychondritis?

A

A rare disorder characterized by inflammation and destruction of cartilaginous structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the most common symptom at the presentation of relapsing polychondritis?

A

Bilateral auricular chondritis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What type of arthritis is associated with relapsing polychondritis?

A

Arthritis, along with other symptoms like fever and neurosensory hearing loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What treatment is typically required for relapsing polychondritis?

A

Corticosteroids.

30
Q

What is seronegative spondyloarthritis?

A

A group of diseases including ankylosing spondylitis and reactive arthritis, characterized by the absence of rheumatoid factor.

31
Q

What are the chronic arthritides associated with idiopathic inflammatory bowel diseases?

A

Ulcerative colitis and Crohn’s disease

These conditions are recognized as distinct from rheumatoid arthritis.

32
Q

What do patients with idiopathic inflammatory bowel diseases not have?

A

Rheumatoid factor or antinuclear antibodies (ANAs)

This distinguishes them from other types of arthritis.

33
Q

Which joints are primarily affected in ankylosing spondylitis?

A

Axial skeleton, especially sacroiliac joints

Joint fusion typically begins in the sacroiliac joints.

34
Q

What are the characteristic radiographic findings in ankylosing spondylitis?

A

Sacroiliitis, squaring of vertebrae, and ossification of spinal ligaments (syndesmophytes)

These findings give the spine a ‘bamboo’ appearance.

35
Q

What percentage of patients with reactive arthritis experience spinal changes such as sacroiliitis?

A

20%

Similar spinal changes can also occur in psoriatic arthritis.

36
Q

What is a common ocular manifestation in patients with spondyloarthritis?

A

Acute anterior uveitis

This occurs in approximately 25% of patients.

37
Q

What is a specific cardiac lesion associated with spondyloarthritides?

A

Aortic regurgitation

Other lesions include atrioventricular or bundle branch conduction defects.

38
Q

What is the association between HLA-B27 positivity and spondylitic heart disease?

A

Found in approximately 5% of ankylosing spondylitis cases

This complication usually occurs after many years of having arthritis.

39
Q

What are the common cardiac manifestations in systemic lupus erythematosus (SLE)?

A

Pericarditis, Libman-Sacks endocarditis, and premature atherosclerosis

Other complications include arrhythmias and myocardial inflammation.

40
Q

What demographic is most susceptible to systemic lupus erythematosus (SLE)?

A

Young women in the childbearing years, especially Africans, Hispanics, and Asians

SLE can occur in people of any age or race.

41
Q

Which autoantibodies are characteristically found in SLE patients?

A

Double-stranded DNA (dsDNA), Smith (Sm), ribonucleoproteins, and histones

These autoantibodies account for positive ANA tests in more than 98% of patients.

42
Q

What is the most common cardiac complication in SLE patients?

A

Pericarditis

Occurs in 19–48% of patients.

43
Q

What is a significant factor contributing to premature atherosclerosis in SLE patients?

A

Immunologic damage and systemic inflammation

Long-term corticosteroid therapy also plays a role.

44
Q

What is the prognosis of systemic lupus erythematosus (SLE) with modern treatment?

A

More than 90% survival at 10 years

This is a significant improvement compared to survival rates in the 1950s.

45
Q

What type of inflammatory lesions are found in the heart of SLE patients?

A

Acute and healed inflammatory lesions with immune complex deposits

The major cause of lupus carditis is believed to be immune complex-mediated injury.

46
Q

What therapy is recommended for mild symptomatic lupus pericarditis?

A

Indomethacin or other NSAIDs

Corticosteroids may be required for more severe cases.

47
Q

What is the typical presentation of pericarditis in SLE patients?

A

Substernal, position-related, pleuritic chest pain

It may be associated with a pericardial rub and diffuse ST-segment elevation on ECG.

48
Q

What is the recommended dose of indomethacin for treating symptoms?

A

75–150 mg/day, divided into three doses

49
Q

What alternative treatment may be used for patients requiring corticosteroids?

A

Low-to-moderate doses of corticosteroids (10–40 mg prednisone equivalent per day)

50
Q

What is the prompt treatment for large effusions or pericardial tamponade?

A

High-dose intravenous corticosteroids (60–80 mg prednisone equivalent per day in two divided doses)

51
Q

What percentage of reported series show clinically evident myocardial involvement?

52
Q

What are some recognized pathologic forms of myocardial involvement?

A

Diffuse small-vessel obliteration and myocyte destruction

53
Q

What causes myocardial involvement in SLE patients?

A

Immune complex deposition, myocardial cell degeneration, lymphocyte infiltration, and antiphospholipid antibodies

54
Q

List the earliest clinical manifestations of myocarditis.

A
  • Resting tachycardia
  • Atypical chest discomfort
  • Third heart sound
  • Nonspecific ST-T wave changes on ECG
55
Q

What can echocardiography reveal in cases of myocarditis?

A
  • Multichamber enlargement
  • Global myocardial dyskinesis
  • Reduced ejection fraction
56
Q

What is the immediate treatment for active myocarditis?

A

Prednisone (60–100 mg/day in two divided doses)

57
Q

What is a significant cause of morbidity and mortality in SLE patients?

A

Premature atherosclerosis

58
Q

What percentage of SLE patients may experience myocardial infarction?

59
Q

What factors contribute to premature atherosclerosis in SLE patients?

A
  • Lupus itself
  • Antiphospholipid antibodies
  • Endothelial dysfunction
  • Traditional cardiovascular risk factors
60
Q

What can coronary artery occlusion in SLE patients result from?

A

Active vasculitis

61
Q

What is Libman-Sacks endocarditis?

A

A sterile verrucous endocarditis affecting the mitral valve leaflets

62
Q

What percentage of lupus patients have Libman-Sacks endocarditis?

A

Approximately 43%

63
Q

What are the typical histological findings in Libman-Sacks endocarditis?

A

Lymphocytes, plasma cells, fibrous tissue, fibrin, platelet thrombi, and occasionally hematoxylin bodies

64
Q

What is a common complication associated with antiphospholipid antibodies?

A

Spontaneous venous or arterial thromboses

65
Q

What is the treatment to reduce thrombotic complications from antiphospholipid antibodies?

A

Chronic anticoagulation with warfarin

66
Q

What is the effect of lupus anticoagulant on clotting indices?

A

Prolongs clotting indices, especially partial thromboplastin time

67
Q

What is the significance of a positive test for antiphospholipid antibodies?

A

Raises clinical suspicion for thrombotic events

68
Q

What is the recommended dose of low-dose aspirin for patients with antiphospholipid antibodies?

69
Q

What may be a potential treatment for lowering antiphospholipid antibody levels?

A

Antimalarials, such as hydroxychloroquine (200 mg/day)

70
Q

What is a primary antiphospholipid antibody syndrome?

A

A condition characterized by clinical thrombotic events and positive tests for anticardiolipin antibodies or lupus anticoagulants without other SLE features

71
Q

What are some cardiac manifestations of antiphospholipid antibodies?

A
  • Verrucous endocarditis (Libman-Sacks)
  • Valvular thickening and contracture
  • Coronary vessel thromboses
  • Mural thrombi